Welcome to our dedicated page for Goodrx Holdings news (Ticker: GDRX), a resource for investors and traders seeking the latest updates and insights on Goodrx Holdings stock.
GoodRx Holdings, Inc. (NASDAQ: GDRX) is widely described as the leading platform for medication savings in the U.S., and its news flow reflects that role at the intersection of digital healthcare, pharmacy, and pharmaceutical manufacturers. Company announcements highlight new partnerships, product launches, and financial updates that shape how consumers, pharmacies, and manufacturers approach prescription affordability.
News about GoodRx often covers collaborations with major healthcare players. Examples include the RxSmartSaver program powered by GoodRx at national and regional retail pharmacies, which brings brand medication savings directly to the pharmacy counter, and an exclusive partnership with Surescripts that integrates GoodRx discounted cash prices into Script Corner, a patient experience product focused on prescription price transparency.
GoodRx also issues press releases on new consumer offerings and subscriptions. Recent updates describe GoodRx for Weight Loss, a telemedicine subscription for GLP-1 weight management treatment, and GoodRx for Hair Loss, a subscription program for men that combines virtual consultations, prescriptions for oral finasteride or oral minoxidil when appropriate, and discreet home delivery. Additional news highlights defined cash prices for medications such as Repatha, Ozempic, Wegovy, and the Wegovy pill at tens of thousands of pharmacies nationwide via GoodRx.
Investors and observers can also find earnings-related news, including quarterly financial results, guidance commentary, and participation in healthcare conferences. Together, these updates provide insight into GoodRx’s strategy across prescription transactions, subscriptions, pharma manufacturer solutions, and telehealth. For anyone tracking GDRX, this news page offers a focused view of how the company is evolving its platform, expanding partnerships, and addressing medication affordability across the U.S. healthcare system.
GoodRx (GDRX) has expanded benefits for its subscription service, GoodRx Gold, offering members exclusive discounts on online doctor visits and free mail delivery. Members can now access affordable healthcare from home, with telehealth visits starting at $10. The service includes mail delivery for over 1,000 medications, with many under $10. After a 30-day free trial, the subscription costs $5.99 monthly for individuals and $9.99 for families. The average member saves over $2,875 annually. GoodRx aims to enhance access to healthcare as telehealth interest rises post-COVID-19 pandemic.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced its third quarter 2020 financial results, highlighting its ongoing mission to make healthcare affordable. With over $25 billion saved by Americans since 2011, GoodRx remains a leading resource for healthcare savings, providing affordable prescriptions and telehealth services. Investors can access the Q3 results and shareholder letter on the investor relations website. A conference call is scheduled for today to discuss these results and the company’s outlook.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced participation in several upcoming virtual investor conferences. Key events include the RBC Capital Markets Conference on November 18 at 7:15am PT, the Credit Suisse Technology Conference on December 3 at 9:50am PT, the UBS Global TMT Conference on December 8 at 11:50am PT, and the Barclays Global Conference on December 10 at 10:00am PT. Live webcasts and archived recordings will be available on the Company’s Investor Relations website post-conference.
GoodRx has saved Americans over $20 billion since 2011.
GoodRx Holdings Inc. (Nasdaq: GDRX) announced the release of its third quarter 2020 financial results on November 12, 2020, before the U.S. market opens. A conference call will follow at 5:30 a.m. PT to discuss the results and future outlook. The company has aided Americans in saving over $20 billion since 2011. GoodRx is recognized as the #1 most downloaded medical app over the past three years, reflecting its strong market presence in consumer-focused digital healthcare.
GoodRx Holdings, Inc. (Nasdaq: GDRX) has renewed its partnership with Kroger Health for three years, enhancing access to the Kroger Rx Savings Club. This initiative aims to help customers save on prescription medications, offering discounts of up to 85% on various generic drugs. Since their collaboration began in 2018, GoodRx has enabled significant savings for over 18 million Americans, totaling $20 billion. The Kroger Rx Savings Club provides multiple tiers of low-cost medications, which are especially beneficial for uninsured individuals or those facing high copays.